Soleus Capital Management, L.P. Organogenesis Holdings Inc. Transaction History
Soleus Capital Management, L.P.
- $1.18 Billion
- Q3 2024
A detailed history of Soleus Capital Management, L.P. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 11,839,876 shares of ORGO stock, worth $37.7 Million. This represents 2.88% of its overall portfolio holdings.
Number of Shares
11,839,876
Previous 11,518,954
2.79%
Holding current value
$37.7 Million
Previous $32.3 Million
4.99%
% of portfolio
2.88%
Previous 3.27%
Shares
13 transactions
Others Institutions Holding ORGO
# of Institutions
117Shares Held
63.2MCall Options Held
25KPut Options Held
23.2K-
Morgan Stanley New York, NY12MShares$38.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$16.2 Million0.0% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M4.84MShares$15.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$11.7 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.02MShares$9.6 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $416M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...